Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release of an HPV vaccine, as well as increased availability of cancer registry data that now include reporting from a large proportion of the US population, prompted the current assessment of HPV-associated cancers. This article describes methods used to assess the burden of HPV-associated cervical, vulvar, vaginal, penile, anal, and oral cavity/oropharyngeal cancers in the United States during 1998 through 2003 using cancer registry data, and it provides a brief overview of the epidemiology of these cancers.
Watson
Meg
M
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. mwatson2@cdc.gov
Saraiya
Mona
M
Ahmed
Faruque
F
Cardinez
Cheryll J
CJ
Reichman
Marsha E
ME
Weir
Hannah K
HK
Richards
Thomas B
TB
D052685:Alphapapillomavirus; D001005:Anus Neoplasms / Q000453:epidemiology / Q000821:virology; D005260:Female; D005833:Genital Neoplasms, Female / Q000453:epidemiology / Q000821:virology; D006801:Humans; D008297:Male; D008722:Methods; D009369:Neoplasms / Q000453:epidemiology* / Q000821:virology*; D009959:Oropharyngeal Neoplasms / Q000453:epidemiology / Q000821:virology; D030361:Papillomavirus Infections / Q000150:complications* / Q000453:epidemiology; D010412:Penile Neoplasms / Q000453:epidemiology / Q000821:virology; D011159:Population Surveillance; D012004:Rectal Neoplasms / Q000453:epidemiology / Q000821:virology; D012042:Registries; D018426:SEER Program; D014481:United States / Q000453:epidemiology